{"id":"W4410032192","doi":"10.3390/ph18050659","title":"A Review of the Clinical Progress of CT1812, a Novel Sigma-2 Receptor Antagonist for the Treatment of Alzheimer’s Disease","year":2025,"lang":"en","type":"review","venue":"Pharmaceuticals","topic":"Pharmacological Receptor Mechanisms and Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Guelph","funders":"","keywords":"Neurodegeneration; Disease; Medicine; Neuroscience; Clinical trial; Antagonist; Alzheimer's disease; Pharmacology; Receptor; Mechanism (biology); Amyloid β; Receptor antagonist; Sigma-1 receptor; Bioinformatics; Internal medicine; Biology; Agonist; Philosophy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004063991,0.0006709207,0.001083168,0.001846953,0.0002267135,0.0006855517,0.0006312495,0.0007060727,0.005186573],"category_scores_gemma":[0.0005371678,0.00025385,0.0006142076,0.001599044,0.0001974686,0.0008015022,0.0003949973,0.001299613,0.002168889],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003796839,"about_ca_system_score_gemma":0.0008425303,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007747432,"about_ca_topic_score_gemma":0.001595933,"domain_scores_codex":[0.9998621,0.00002521397,0.00002696198,0.00002399941,0.00004965627,0.00001203224],"domain_scores_gemma":[0.9998345,0.00007181209,0.00002508051,0.000003806729,0.00004895113,0.00001575893],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001585745,0.0001041147,0.0001036186,0.03439547,0.0001319037,0.0002192604,0.00007460942,0.0002924087,0.002728334,0.002251451,0.03920275,0.9203374],"study_design_scores_gemma":[0.00004777152,0.0002591616,0.0006985081,0.005427011,0.0002438383,0.001008478,0.00004703843,0.00008619827,0.0005815279,0.0008068021,0.9907737,0.00001995478],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001839693,0.9981237,0.0001106876,0.0002195651,0.0002189153,0.00001025526,0.00004509135,0.00000817212,0.001079652],"genre_scores_gemma":[0.0005341799,0.9983437,0.000182946,0.0002050211,0.0001141173,0.00001199376,0.00005163999,0.000001583874,0.0005548305],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005186573,"threshold_uncertainty_score":0.01735085,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1883616824215025,"score_gpt":0.5108669394468865,"score_spread":0.3225052570253841,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}